AVROBIO
+$0.0178 (+2.00%) Today
$0.00 (0.00%) As of 9:16 PM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AVROBIO and other ETFs, options, and stocks.
About AVRO
Avrobio, Inc. engages in the development of lentiviral-based gene therapies. It focuses on developing potentially curative ex vivo lentiviral-based gene therapies to treat patients with rare diseases following a single dose treatment regimen.
CEO
Geoff MacKay
Employees
122
Headquarters
Cambridge, Massachusetts
Founded
2015
AVRO Key Statistics
Market cap
39.66M
Price-Earnings ratio
—
Dividend yield
—
Average volume
343.84K
High today
$0.9511
Low today
$0.85
Open price
$0.8736
Volume
462.40K
52 Week high
$11.00
52 Week low
$0.74
Analyst ratings
67%
of 9 ratings
Buy
66.7%
Hold
33.3%
Sell
0%
AVRO Earnings
-$1.01
-$0.67
-$0.34
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, Pre-Market